Gain Therapeutics
Founded
2017
2017
Geography
Switzerland based
Switzerland based
Funding
$14.415 M
$14.415 M
Gain Therapeutics is a preclinical stage biotech company developing a class of next generation brain-penetrant non-competitive pharmacological chaperones for the treatment of devastating diseases using the proprietary SEE-Tx® technology.
Technologies
AI Companies (Drug Discovery)R&D Platform
-
Pipelines
No pipelines published yet
Products
Services
No services posted yet
